GenMont Biotech Incorporation (3164.TW) TAI

18.20

+0.05(+0.28%)

Updated at January 14 01:30PM

Currency In TWD

Valuation

Market Cap1.75B
Enterprise Value1.76B
P/E Ratio44.9
PEG Ratio0.37
Price/Sales Ratio4
Price/Book Ratio1.21
Enterprise/Revenue4.08
Enterprise/EBITDA14.85

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.09
Operating Margin0.11

Management Effectiveness

Return On Assets0.02
Return On Equity0.03

Income Statement

Revenue385.37M
Revenue/Share4.6
Gross Profit238.18M
EBITDA140.03M
Net Income57.25M
Diluted EPS0.66

Balance Sheet

Total Cash382.48M
Total Cash/Share4.49
Total Debt106M
Total Debt/Equity0.08
Current Ratio4.82
Book Value Per Share16.37

Price History

52-Week Change-5.45
52-Week High23.35
52-Week Low17.2
Moving Average 50 Days18.38
Moving Average 200 Days19.52

Statistics

Average Volume28,427
Shares Outstanding86.01M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.8
Trailing Annual Dividend Yield4.4
Payout Ratio2.01
Last Split Factor11:10
Last Split DateJune 15, 2010